Upon the start of the COVID-19 pandemic, testing was limited in number and capability. But now, testing is faster and more accessible and ubiquitous. RADx, a federal health-ran initiative to improve testing, is the program behind how we got to where we are. We talk to experts behind RADx about the technologies behind improvements in testing, challenges in testing underserved populations and the future of at-home testing.
| Episode: 23
The Rapid Acceleration of Diagnostics program, or RADx, brought scalability and advancements to COVID-19 testing.
Michael Wolfson, Program Manager, NIBIB
Dr. Monica Webb Hooper, Deputy Director, NIMHD
Liz DiNenno, Associate Deputy Director for Surveillance, Epidemiology and Laboratory Sciences, CDC